Jefferies likes these dividend-growing stocks for 2024
Investors searching for income could be well-rewarded by turning to dividend-growing stocks, according to Jefferies. Source link
Read More
Cerevel Therapeutics Holdings Inc
‘This is the mental health moment’: Innovation and M&A are helping to boost these stocks to new heights
Two recent M&A announcements by big pharma are creating excitement among investors. Here's who is poised to benefit. Source link
Read More
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. A look at what 2024 might
Read More
Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push
Bristol Myers Squibb said on Tuesday it would buy RayzeBio for about $4.1 billion to bolster its cancer drug business.
Read More
Stocks making the biggest moves midday: Advanced Micro Devices, Alphabet, Sprinklr, Chewy and more
These are the stocks posting the largest moves in midday trading. Source link
Read More
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
The deal is AbbVie's latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic
Read More
Bank of America just added these biotech stocks to its list of first-quarter picks
The biotech sector is hot on Wall Street right now. Here are some of Bank of America's favorite stocks going
Read More